Funded Startups in Encinitas
Encinitas’ most recent disclosed rounds show a sharp size split.
Encinitas’ most recent disclosed rounds show a sharp size split. The largest disclosed round is Vuori’s $400M (2021-10-13), which dwarfs the next-largest disclosed amounts in this list ($114M for Neurelis on 2021-03-10, and $60M for Flock Freight on 2025-05-14). At the smaller end, the list’s smallest disclosed amount is $100K for Sequoia (2022-01-18), while Tempello’s 2023-12-15 round is labeled “undisclosed.”
The entries also cluster by time rather than staying evenly distributed: five of the 14 rows fall between 2024-02-19 and 2025-05-14, and two additional biotech rounds bookend the earlier period (Neurelis 2021-03-10 and Sequoia 2022-01-18). Sector presence is uneven, with Biotechnology appearing 3+ times (Dermata Therapeutics 2025-01-22, Sequoia 2022-01-18, Neurelis 2021-03-10). Stage labeling is also partly opaque: “Series Unknown” appears 3 times (Dermata Therapeutics 2025-01-22; Nixon 2023-08-17; Hone 2022-08-22), plus one “undisclosed” amount (Tempello 2023-12-15). Overall, round dates span 2021-03-10 through 2025-05-14 across 14 rows.
Most recent rounds
14 shownRelated listings
Frequently asked
What’s the largest disclosed round in Encinitas on this list, and how does it compare with the rest of the disclosed amounts?
Vuori’s disclosed $400M (2021-10-13) is an outlier in size versus the rest of the disclosed rounds, with the next-largest being Neurelis at $114M (2021-03-10) and Flock Freight at $60M (2025-05-14). At the low end, Sequoia’s smallest disclosed amount is $100K (2022-01-18), while Tempello is the only row marked “undisclosed” (2023-12-15).
Do the most recent rounds cluster into a narrow time window, or are they spread out across the full date range?
They cluster toward the top of the date range: five of the 14 rows fall between 2024-02-19 (9amHealth) and 2025-05-14 (Flock Freight). The earliest dated entry shown is Neurelis on 2021-03-10, so the set spans 2021-03-10 to 2025-05-14 rather than forming a single tight window.
Which sectors are over-represented in this Encinitas set of 14 rows?
Biotechnology shows up at least three times: Dermata Therapeutics ($3M, 2025-01-22), Sequoia ($100K, 2022-01-18), and Neurelis ($114M, 2021-03-10). Other categories appear in fewer entries per the rows shown (e.g., Clothing and Apparel includes Nixon and Vuori).
How much of the list is hard to classify by stage label (Series Unknown or undisclosed)?
Stage labeling is partially opaque. “Series Unknown” appears 3 times (Dermata Therapeutics on 2025-01-22 for $3M; Nixon on 2023-08-17 for $23M; Hone on 2022-08-22 for $29M), and one entry has an “undisclosed” amount (Tempello on 2023-12-15).
Are there notable stage and size combinations that stand out for analysts tracking investment maturity?
Higher-maturity labeled rounds vary widely in size: Vuori is categorized as “Venture - Series Unknown” with $400M (2021-10-13), while Neurelis shows “Series D” at $114M (2021-03-10). Meanwhile, several smaller early-stage outcomes are visible, such as Hume Supernatural’s Seed at $200K (2024-07-24) and Shadowbox’s Series A at $2M (2024-10-31).
Which entries fall at the top of the timeline, and do they point to a recent shift in sector mix?
The most recent rounds are Flock Freight (Series E, $60M on 2025-05-14), Dermata Therapeutics (Series Unknown, $3M on 2025-01-22), and Shadowbox (Series A, $2M on 2024-10-31). In that late period, the visible sectors span Software, Biotechnology, and Health Care, even as Biotechnology also appears in earlier years via Sequoia (2022-01-18) and Neurelis (2021-03-10).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.